Bengt Westermark

Prof. Bengt Westermark

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 1999 in Physiological Reviews
Verified
Journal Article
Closed access
PDF file
CHCarl-Henrik Heldin
Carl-Henrik Heldin
BWBengt Westermark
Bengt Westermark
Platelet-derived growth factor (PDGF) is a major mitogen for connective tissue cells and certain other cell types. It is a dimeric molecule consisting of disulfide-bonded, structurally similar A- and B-polypeptide chains, which combine to homo- and heterodimers. The PDGF isoforms exert their cellular effects by binding to and activating two structurally related protein tyrosine kinase receptors, denoted the α-receptor and the β-receptor. Activation of PDGF receptors leads to stimulation of cell growth, but also to changes in cell shape and motility; PDGF induces reorganization of the actin filament system and stimulates chemotaxis, i.e., a directed cell movement toward a gradient of PDGF. In vivo, PDGF has important roles during the embryonic development as well as during wound healing. Moreover, overactivity of PDGF has been implicated in several pathological conditions. Thesis oncogene of simian sarcoma virus (SSV) is related to the B-chain of PDGF, and SSV transformation involves autocrine stimulation by a PDGF-like molecule. Similarly, overproduction of PDGF may be involved in autocrine and paracrine growth stimulation of human tumors. Overactivity of PDGF has, in addition, been implicated in nonmalignant conditions characterized by an increased cell proliferation, such as atherosclerosis and fibrotic conditions. This review discusses structural and functional properties of PDGF and PDGF receptors, the mechanism whereby PDGF exerts its cellular effects, and the role of PDGF in normal and diseased tissues.

31 August 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MAMarie Allen
Marie Allen
MBMia Bjerke
Mia Bjerke
HEHanna Edlund
Hanna Edlund
SNSven Nelander
Sven Nelander
BWBengt Westermark
Bengt Westermark
The DNA profile of the publicly available and widely used glioma cell line U87MG is quite different from that of the original cell line.

1 October 2015 in EBioMedicine
Verified
Journal Article
Open access
YXYuan Xie
Yuan Xie
TBTobias Bergström
Tobias Bergström
YJYiwen Jiang
Yiwen Jiang
PJPatrik Johansson
Patrik Johansson
VMVoichita Dana Marinescu
Voichita Dana Marinescu
LULene Uhrbom
Lene Uhrbom
Glioblastoma (GBM) is the most frequent and malignant form of primary brain tumor. GBM is essentially incurable and its resistance to therapy is attributed to a subpopulation of cells called glioma stem cells (GSCs). To meet the present shortage of relevant GBM cell (GC) lines we developed a library of annotated and validated cell lines derived from surgical samples of GBM patients, maintained under conditions to preserve GSC characteristics. This collection, which we call the Human Glioblastoma Cell Culture (HGCC) resource, consists of a biobank of 48 GC lines and an associated database containing high-resolution molecular data. We demonstrate that the HGCC lines are tumorigenic, harbor genomic lesions characteristic of GBMs, and represent all four transcriptional subtypes. The HGCC panel provides an open resource for in vitro and in vivo modeling of a large part of GBM diversity useful to both basic and translational GBM research.

1 August 1998 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MAMozhgan Afrakhte
Mozhgan Afrakhte
AMAnita Morénb
Anita Morénb
SJSurinder Jossana
Surinder Jossana
SISusumu Itohb
Susumu Itohb
KSKuber Sampathc
Kuber Sampathc
PDPeter Ten Dijke
Peter Ten Dijke

1 December 2016 in Cell Reports
Verified
Journal Article
Open access
ASAnna Segerman
Anna Segerman
MNMia Niklasson
Mia Niklasson
CHCaroline Haglund
Caroline Haglund
TBTobias Bergström
Tobias Bergström
MJMalin Jarvius
Malin Jarvius
BWBengt Westermark
Bengt Westermark
Intratumoral heterogeneity is a hallmark of glioblastoma multiforme and thought to negatively affect treatment efficacy. Here, we establish libraries of glioma-initiating cell (GIC) clones from patient samples and find extensive molecular and phenotypic variability among clones, including a range of responses to radiation and drugs. This widespread variability was observed as a continuum of multitherapy resistance phenotypes linked to a proneural-mesenchymal shift in the transcriptome. Multitherapy resistance was associated with a semi-stable cell state that was characterized by an altered DNA methylation pattern at promoter regions of mesenchymal master regulators and enhancers. The gradient of cell states within the GIC compartment constitutes a distinct form of heterogeneity. Our findings may open an avenue toward the development of new therapeutic rationales designed to reverse resistant cell states.

1 January 2016 in Cell Reports
Verified
Journal Article
Open access
SDSpyros Darmanis
Spyros Darmanis
CGCaroline Julie Gallant
Caroline Julie Gallant
VMVoichita Dana Marinescu
Voichita Dana Marinescu
MNMia Niklasson
Mia Niklasson
ASAnna Segerman
Anna Segerman
ULUlf Landegren
Ulf Landegren
Significant advances have been made in methods to analyze genomes and transcriptomes of single cells, but to fully define cell states, proteins must also be accessed as central actors defining a cell's phenotype. Methods currently used to analyze endogenous protein expression in single cells are limited in specificity, throughput, or multiplex capability. Here, we present an approach to simultaneously and specifically interrogate large sets of protein and RNA targets in lysates from individual cells, enabling investigations of cell functions and responses. We applied our method to investigate the effects of BMP4, an experimental therapeutic agent, on early-passage glioblastoma cell cultures. We uncovered significant heterogeneity in responses to treatment at levels of RNA and protein, with a subset of cells reacting in a distinct manner to BMP4. Moreover, we found overall poor correlation between protein and RNA at the level of single cells, with proteins more accurately defining responses to treatment.